關鍵數據
3.310今開
3.370最高
87.44K成交量
15.97本益比TTM
968.98本益比動
--股利TTM
0.06%換手率
3.310昨收
3.220最低
290.32K成交額
11.42本益比靜
2.29市淨率
0.00%股息率 TTM
10.60%ROA
7.66052週最高
0.04量比
42.42M淨利潤
145.93M總股本
0.2078每股盈餘TTM
1.47Beta
13.77%ROE
3.03052週最低
4.99%振幅
79.33%毛利率
484.49M總市值
-0.56回報/風險
2.72%風險率

即將為您帶來更多新聞,敬請期待。 。 。
MiMedx Group Inc評分
0.18與上次評分對比預測8.00
財務診斷7.75
技術分析5.89
公司估值8.63
機構認同度7.00
風險評估6.05
分析師評級
MiMedx Group Inc 最新財報電話會記錄
MiMedx (MDXG) 2026年第三季法說會:外科業務成長與最新財測指引
MiMedx 2026 年第三季財報電話會議:外科業務銷售額成長 9%,傷口照護業務下降 71%,調整後 EBITDA 轉為正值,並更新了 2026 年銷售額財測指引。
財務指標
貨幣: USD

由於公司未披露,未能獲取相關數據
貨幣: USD

由於公司未披露,未能獲取相關數據
MiMedx Group Inc 簡介
MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.
行業生物技術與醫療研究
公司代碼MDXG
員工數量837
國家United States of America
持股情況
| 持股股東 | 佔比 |
|---|
| EW Healthcare Partners | 18.93% |
|---|
| BlackRock Institutional Trust Company, N.A. | 5.90% |
|---|
| Trigran Investments, Inc. | 4.14% |
|---|
| Vanguard Capital Management, LLC | 3.47% |
|---|
| 股東類型 | 佔比 |
|---|
| Investment Advisor | 20.19% |
|---|
| Investment Advisor/Hedge Fund | 19.89% |
|---|
| Venture Capital | 18.93% |
|---|
| Hedge Fund | 11.86% |
|---|
常見問題
MiMedx Group Inc(MDXG)的當前股價是多少?
MiMedx Group Inc(MDXG)的當前股價是 3.32。
MiMedx Group Inc 的股票代碼是什麼?
MiMedx Group Inc的股票代碼是MDXG。
MiMedx Group Inc股票的52週最高點是多少?
MiMedx Group Inc股票的52週最高點是7.77。
MiMedx Group Inc股票的52週最低點是多少?
MiMedx Group Inc股票的52週最低點是3.03。
MiMedx Group Inc的市值是484.49M。
現在MiMedx Group Inc(MDXG)的股票是買入、持有還是賣出?
根據分析師評級,MiMedx Group Inc(MDXG)的總體評級為買入,目標價格為7.00。
MiMedx Group Inc(MDXG)股票的每股收益(EPS TTM)是多少
MiMedx Group Inc(MDXG)股票的每股收益(EPS TTM)是0.21。